AXSM vs PPC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AXSM · Axsome Therapeutics$129.36 ▼ 4.66%
PPC · Pilgrim's Pride$28.60 ▲ 3.47%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AXSM -14.4%
- PPC -23.6%
Head to head
| Metric | AXSM | PPC |
|---|---|---|
| Price | $129.36 | $28.60 |
| Change today | ▼ 4.66% | ▲ 3.47% |
| Market cap | $6.80B | $6.81B |
| Return, 3 months | -37.0% | -10.0% |
| Return, year to date | -29.2% | -26.6% |
| Return, 1 year | -13.4% | -26.3% |
| P/E (TTM) | – | 21.3 |
| P/B | 64.6 | 1.8 |
| P/E percentile vs own 5y | 10th | 74th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +51.9% | -2.2% |
| Net profit growth (YoY) | +72.7% | -66.1% |
| Gross margin | 93.2% | 7.9% |
| Operating margin | -18.9% | 3.5% |
| Net margin | -18.2% | 1.7% |
| Return on equity | -175.6% | 8.6% |
| Analyst target vs. price | +104.0% | +24.1% |
| Analyst buy share | 94% | 50% |
| RSI (14) | 33 | 52 |
| 30-day volatility | 50.8% | 44.5% |
| Max drawdown, 1 year | -49.3% | -42.4% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PPC is the largest of the group by market value.
- AXSM has returned the most over the past year.
- AXSM is growing revenue fastest.
- PPC keeps the most profit per dollar of sales.
- PPC has been the calmest stock over the last 30 days.